Skip to content

Smoking Cessation for Patients With Acute Coronary Syndrome (ACS)

Effectiveness of a Managed Care Smoking Cessation Program in Patients With Acute Coronary Syndrome Based on Nicotine Replacement as a Treatment and a Cognitive-behavioral Approach

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00987597
Acronym
PATPAC
Enrollment
144
Registered
2009-10-01
Start date
2008-09-30
Completion date
2010-04-30
Last updated
2016-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Smoking

Keywords

Smoking, nicotine replacement, psychological behaviour, Smoking > 5 cigarettes per day, Hospitalisation for acute coronary syndrome

Brief summary

The aim of the present study is to assess if a personal care program of smokers hospitalised for acute coronary syndrome can change the smoking habits as compared with similar patients in conventional care program at 6 months. The program includes a cognitive-behavioural approach associated with a nicotine replacement treatment presented as an obligatory non optional treatment. Patients are men and women of less than 70 years old hospitalised for acute coronary syndrome. Major exclusion criteria is the presence of another dependence. The program includes a cognitive-behavioural approach based on the specific technique of exposure and the prescription of nicotine patch considered as other usual cardiologic treatments for at least 6 months. The end point is the smoking habits at 6 months classified as: no smoking confirmed by CO measurement, smoking or doubtful (declaration of no smoking by the patient but a CO level \> 10 ppm). 72 patients in each group will be included in 2 majors sites.

Detailed description

The cognitive behavioural approach group : This group will receive an inclusion visit at first, then two cigaret exposures cessions during hospitalisation. Thereafter-one week after he's out- the patient will come for 5 follow up visits consisting in the specific technique of cigaret exposure and nicotinic treatment adjustment. Then the last visit, at six months, will tell us if the patient is an effective non smoker or not; We'll be also collecting psychological and medical informations (such as the treatment, IMC, cardiovascular check up and psychological tests). The control group : This group is managed as usual : the nurse gives very rapid recommendations to the patients concerning smoking cessation. Nicotinic substitutes are proposed to the patients but the patient must find them by itself.

Interventions

BEHAVIORALTechnique of in-vivo exposure (cigarette) and mental image exposure (craving)

Nicotine replacement

nicotinic substitutes

Sponsors

Ministry of Health, France
CollaboratorOTHER_GOV
National Cancer Institute, France
CollaboratorOTHER_GOV
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients are men and women of less than 70 years old * Hospitalised for acute coronary syndrome in cardiology Intensive Care Unit * Active smoking \>5 cigarettes/day * Has given consent to participate in the study and haven't expressed its opposition the exploitation of data as part of the study

Exclusion criteria

* Presence of another dependence : alcohol abuse avowed or strongly suspected, addiction to drugs, high dose benzodiazepine dependence. clinical assessment * Major psychiatric disorders or history. clinical assessment * Treatment with lithium and neuroleptic. clinical assessment * Patient whose cardiac problem could lead to hemodynamic instability during 48 h after admission. * Patient scheduled for programmed hospitalisation within 6 months after release from hospital (\>3 days long, including coronary bypass) * Patients presenting another severe pathology requiring 6 months specific treatments. clinical assessment * Patient which cannot understand or read French * Patient with possible side-effect to nicotine substitute * Patient unaffiliated to any social security regime

Design outcomes

Primary

MeasureTime frame
The smoking habits at 6 months classified as : no smoking confirmed by CO measurement, smoking or doubtful (declaration of no smoking by the patient but a CO level > 10 ppm).6 month

Secondary

MeasureTime frame
Assessment depending of age classes, sex, anxiety scale and other psychological characteristics6 month

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026